Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 21, 2011
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapyNikolaus Kohles, Dorothea Nagel, Dietrich Jüngst, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 11, 2013
Diagnostic relevance of plasma DNA and DNA integrity for breast cancerOliver J Stötzer, Julia Lehner, Debora Fersching-Gierlich, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 26, 2006
Nucleosomes in colorectal cancer patients during radiochemotherapyAndreas Kremer, Stefan Holdenrieder, Petra Stieber, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 10, 2005
Nucleosomes in pancreatic cancer patients during radiochemotherapyAndreas Kremer, Ralf Wilkowski, Stefan Holdenrieder, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Serum HER2 in combination with CA 15-3 as a parameter for prognosis in patients with early breast cancerDorit Di Gioia, Marie Dresse, Doris Mayr, et al.
International Journal of Cancer|August 12, 2005
Soluble MICA in malignant diseasesStefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2006
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICAStefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.
International Journal of Cancer|June 5, 2013
Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapyChristin Wittwer, Stefan Boeck, Volker Heinemann, et al.
Anticancer Research|July 26, 2007
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patientsDorit Laessig, Dorothea Nagel, Volker Heinemann, et al.
Pageof 8